We explored how the collagen supplement BD400 affects rheumatoid arthritis (RA) using a collagen-induced arthritis rat model.
Our findings indicated that BD400 significantly reduced arthritis symptoms, including joint swelling and inflammation. It also positively influenced gut health by restoring intestinal permeability and altering gut microbiota composition.
Ultimately, our study suggests that BD400 can slow the progression of RA by down-regulating certain inflammatory factors and enhancing gut barrier function, presenting an interesting potential for autoimmune disorder management.
Read More
GSZD reduces RA symptoms effectively decoction attenuates bone erosion in rats that have collagen-induced arthritis via modulating NF-κB signalling to suppress osteoclastogenesis.
Study shows strong treatment potential.
We explored the effects of decoction (GSZD) on bone erosion linked to rheumatoid arthritis (RA) in a rat model. Our study involved various groups receiving either GSZD or standard treatments, monitoring changes in paw volume and arthritic severity.
The findings showed that GSZD significantly improved inflammatory symptoms and reduced joint tissue erosion. It decreased markers of osteoclasts and enhanced protective factors, suggesting promising potential for GSZD as a supplement in treating RA without pronounced adverse effects.
Read More
CCFM1074 benefits arthritis management CCFM1074 Alleviates Collagen-Induced Arthritis in Rats Balancing Treg/Th17 and Modulating the Metabolites and Gut Microbiota.
Findings relevant to autoimmune research
We assessed the effects of collagen supplements, specifically strain CCFM1074, on arthritis in rats. This study utilized a robust method that examined the immune responses, gut microbiota, and various metabolites.
Our findings revealed that CCFM1074 successfully reduced symptoms of arthritis, enhancing beneficial immune responses while modulating gut microbiota and metabolites. Meanwhile, another strain, CCFM1075, did not show significant benefits.
Overall, CCFM1074 appears to balance immune functions and improve gut health, suggesting its potential role in managing autoimmune disorders.
Read More
We examined the anti-inflammatory properties of liposome/gold hybrid nanoparticles that contain Coenzyme Q10 (LGNP-CoQ10) in a model of rheumatoid arthritis in mice. Over 10 weeks, we treated the mice with LGNP-CoQ10 and noted that it significantly reduced inflammation and levels of specific pro-inflammatory factors.
Moreover, the treatment showed a decrease in pro-inflammatory cell populations, indicating a reduced inflammatory response that could benefit those suffering from rheumatoid arthritis. Our findings highlight the promising therapeutic potential of LGNP-CoQ10 in managing inflammatory autoimmune disorders.
Read More
We explored how Hsp65, a protein delivered by beneficial bacteria, can help prevent arthritis in mice. In our study, continuous delivery in the gut led to the creation of regulatory T cells that successfully blocked the onset of arthritis. We observed reduced clinical signs of arthritis and lower inflammation markers, like IL-17 and anti-collagen antibodies. This approach appears to modify gut bacteria and enhance immune tolerance, suggesting Hsp65 could potentially be a new tool for treating autoimmune diseases.
Read More